- Investing Ideas
- Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Results
7
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
7 companies
argenx
Market Cap: €53.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€855.20
7D
11.5%
1Y
49.1%
UCB
Market Cap: €41.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€215.40
7D
-4.3%
1Y
10.2%
Celyad Oncology
Market Cap: €12.0m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.28
7D
9.0%
1Y
-29.2%
Hyloris Pharmaceuticals
Market Cap: €125.7m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.49
7D
-0.9%
1Y
-29.8%
Financière de Tubize
Market Cap: €8.2b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€184.80
7D
-3.4%
1Y
15.5%
Oxurion
Market Cap: €212.9k
A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.
OXUR
€0.0024
7D
-14.3%
1Y
-90.3%
BioSenic
Market Cap: €1.3m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.002
7D
0%
1Y
-23.1%